ENTITY
Broncus

Broncus (2216 HK)

21
Analysis
Health Care • China
Broncus is a medical device company focused on the research, development, manufacturing, and commercialization of innovative solutions for lung diseases. The company provides diagnostic solutions, lung cancer treatment solutions, and chronic obstructive pulmonary disease (COPD) solutions, including navigation platforms and interventional therapeutic devices like the InterVapor system and BroncAblate. Broncus was founded in 2012 and is headquartered in Hangzhou, China.
more
Exchange Announcement • 21 Sep 2026 06:44

Major Transaction - Termination Of The Share Transfer Agreement

Exchange Announcement • 18 Sep 2026 16:37

Reminder Letter And Reply Form To Non-Registered Shareholders - Arrangement Of Electronic Dissemination Of Corporate Communications

Exchange Announcement • 18 Sep 2026 16:34

Reminder Letter And Reply Form To Registered Shareholders - Arrangement Of Electronic Dissemination Of Corporate Communications

Exchange Announcement • 18 Sep 2026 16:32

Interim Report 2026

Exchange Announcement • 31 Aug 2026 19:51

Further Delay In Despatch Of Circular Major Transaction Further Acquisition Of Target Shares In The Target Company

x